Filter
292
Filtered Results: 292
Text search:
inactivated
vaccines
Featured
Recommendations
35
New Publications
83
Language
Document type
No document type
129
Guidelines
75
Studies & Reports
37
Fact sheets
18
Manuals
17
Strategic & Response Plan
7
Situation Updates
5
Training Material
3
Resource Platforms
1
Countries / Regions
Global
10
India
9
Pakistan
8
Germany
8
South Africa
7
Sierra Leone
6
Nigeria
6
Philippines
6
Afghanistan
5
Syria
5
Tanzania
5
Latin America and the Carribbean
5
Uganda
4
Kenya
4
Ukraine
4
Chile
4
Ethiopia
3
Nepal
3
Africa
3
Liberia
2
Congo, Democratic Republic of
2
Rwanda
2
Namibia
2
Myanmar / Burma
2
Yemen
2
East and Southern Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Venezuela
2
Zimbabwe
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Zambia
1
Turkey
1
Egypt
1
China
1
Bangladesh
1
Malawi
1
Papua New Guinea
1
Argentina
1
Peru
1
Brazil
1
Colombia
1
Ecuador
1
Botswana
1
Bolivia
1
Libya
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
82
Clinical Guidelines
41
Women & Child Health
14
Key Resources
7
Public Health
6
Pharmacy & Technologies
6
Capacity Building
1
Toolboxes
COVID-19
73
Polio
29
Rapid Response
20
Ebola
13
Pharmacy
13
Refugee
10
HIV
10
TB
10
NTDs
10
AMR
8
Cholera
7
Conflict
7
Zika
4
Natural Hazards
3
Planetary Health
3
Mental Health
2
Specific Hazards
1
Global Health Education
1
Health Financing Toolbox
1
NCDs
1
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
first issued 18 August 2022
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
Available in different languages
It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following:
an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
an A(H3N2) virus to be announced on 21 March 2019*...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
